These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16875808)

  • 1. Distribution characteristics of orally administered olamufloxacin, a newly synthesized fluoroquinolone antibacterial, in lung epithelial lining fluid and alveolar macrophage in rats.
    Sun J; Deguchi Y; Tauchi Y; He Z; Cheng G; Morimoto K
    Eur J Pharm Biopharm; 2006 Oct; 64(2):238-45. PubMed ID: 16875808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution characteristics of grepafloxacin, a fluoroquinolone antibiotic, in lung epithelial lining fluid and alveolar macrophage.
    Deguchi Y; Sun J; Tauchi Y; Sakai S; Morimoto K
    Drug Metab Pharmacokinet; 2003; 18(5):319-26. PubMed ID: 15618751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration of enrofloxacin and its active metabolite in alveolar macrophages and pulmonary epithelial lining fluid of dogs.
    Hawkins EC; Boothe DM; Guinn A; Aucoin DP; Ngyuen J
    J Vet Pharmacol Ther; 1998 Feb; 21(1):18-23. PubMed ID: 9507453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages.
    Togami K; Chono S; Morimoto K
    Biopharm Drug Dispos; 2011 Oct; 32(7):389-97. PubMed ID: 21812004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects.
    Gotfried MH; Danziger LH; Rodvold KA
    J Antimicrob Chemother; 2003 Sep; 52(3):450-6. PubMed ID: 12888589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
    Conte JE; Golden JA; McIver M; Zurlinden E
    Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
    Higa F; Arakaki N; Tateyama M; Koide M; Shinzato T; Kawakami K; Saito A
    J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier-mediated lung distribution of HSR-903, a new quinolone antibacterial agent.
    Murata M; Tamai I; Sai Y; Nagata O; Kato H; Tsuji A
    J Pharmacol Exp Ther; 1999 Apr; 289(1):79-84. PubMed ID: 10086990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between quinolone antibiotics and phospholipid membrane for prediction of alveolar macrophage uptake in vitro.
    Sun J; Deguchi Y; Chen JM; Zhang RH; Morimoto K
    Acta Pharmacol Sin; 2002 May; 23(5):430-8. PubMed ID: 11978193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the concentration of marbofloxacin in alveolar macrophages and pulmonary epithelial lining fluid after administration in dogs.
    Boothe HW; Jones SA; Wilkie WS; Boeckh A; Stenstrom KK; Boothe DM
    Am J Vet Res; 2005 Oct; 66(10):1770-4. PubMed ID: 16273909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of clarithromycin in bronchial epithelial lining fluid.
    Kikuchi E; Yamazaki K; Kikuchi J; Hasegawa N; Hashimoto S; Ishizaka A; Nishimura M
    Respirology; 2008 Mar; 13(2):221-6. PubMed ID: 18339019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrapulmonary Pharmacokinetics of Levonadifloxacin following Oral Administration of Alalevonadifloxacin to Healthy Adult Subjects.
    Rodvold KA; Gotfried MH; Chugh R; Gupta M; Yeole R; Patel A; Bhatia A
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
    Togami K; Chono S; Morimoto K
    J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):110-5. PubMed ID: 22360316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin.
    Lucchi M; Damle B; Fang A; de Caprariis PJ; Mussi A; Sanchez SP; Pasqualetti G; Del Tacca M
    J Antimicrob Chemother; 2008 Apr; 61(4):884-91. PubMed ID: 18252692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin.
    Gontijo AV; Brillault J; Grégoire N; Lamarche I; Gobin P; Couet W; Marchand S
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3942-9. PubMed ID: 24798283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efflux transport of a new quinolone antibacterial agent, HSR-903, across the blood-brain barrier.
    Murata M; Tamai I; Kato H; Nagata O; Tsuji A
    J Pharmacol Exp Ther; 1999 Jul; 290(1):51-7. PubMed ID: 10381759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of sparfloxacin and ciprofloxacin into alveolar macrophages, epithelial lining fluid, and polymorphonuclear leucocytes.
    Schüler P; Zemper K; Borner K; Koeppe P; Schaberg T; Lode H
    Eur Respir J; 1997 May; 10(5):1130-6. PubMed ID: 9163658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections.
    Zhang J; Xie X; Zhou X; Chen YQ; Yu JC; Cao GY; Wu XJ; Shi YG; Zhang YY
    J Clin Pharmacol; 2010 Aug; 50(8):922-8. PubMed ID: 20035039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Designs of optimized microbial therapy systems of respiratory infections].
    Morimoto K
    Yakugaku Zasshi; 2013; 133(1):81-92. PubMed ID: 23292024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic efficacy of intrapulmonary administration of ciprofloxacin for the treatment of respiratory infections.
    Chono S; Tanino T; Seki T; Morimoto K
    Drug Metab Pharmacokinet; 2007 Apr; 22(2):88-95. PubMed ID: 17495415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.